High-yield overview

ECM Macromolecules | 28 Collagen Types | GAG Side Chains | Triple Helix Structure

28Collagen types identified

90%Type I collagen in bone/tendon

300nmTropocollagen length

67nmD-band periodicity

MAJOR COLLAGEN TYPES

Type I

PatternBone, tendon, ligament, skin

TreatmentMost abundant, fibril-forming

Type II

PatternHyaline cartilage, nucleus pulposus

TreatmentFibril-forming, smaller diameter

Type III

PatternBlood vessels, skin, healing tissue

TreatmentReticular fibers, with Type I

Type IV

PatternBasement membranes

TreatmentNetwork-forming, non-fibrillar

Critical Must-Knows

Collagen is most abundant protein in mammals (25-35% of total body protein)
Triple helix structure - Gly-X-Y repeat with glycine every third residue
Proteoglycans consist of core protein with GAG side chains
Aggrecan is major cartilage proteoglycan, decorin binds collagen
Hydroxylation requires Vitamin C - scurvy impairs collagen synthesis

Clinical Pearls

"
Type I collagen mutations cause osteogenesis imperfecta
"
Type II collagen mutations cause chondrodysplasias
"
Lysyl oxidase creates crosslinks (requires copper)
"
GAG side chains on proteoglycans attract water via negative charge

Critical Collagen and Proteoglycan Exam Points

Triple Helix Structure

Collagen has unique triple helix with Gly-X-Y amino acid repeat. Glycine (smallest amino acid) must be every third residue to fit in center of helix. Proline and hydroxyproline common in X and Y positions. Mutations replacing glycine cause structural diseases (OI, EDS).

Post-Translational Modifications

Hydroxylation of proline and lysine requires Vitamin C (cofactor for prolyl and lysyl hydroxylases). Scurvy causes defective collagen. Lysyl oxidase (requires copper) creates crosslinks between collagen molecules, essential for tensile strength.

Proteoglycan Structure

Proteoglycans are core protein with GAG side chains (chondroitin sulfate, keratan sulfate, heparan sulfate, dermatan sulfate). GAGs are repeating disaccharides with sulfate/carboxyl groups creating negative charge. Attract water and cations.

Tissue-Specific Distribution

Type I collagen: bone (90%), tendon, ligament, skin. Type II: hyaline cartilage, nucleus pulposus. Type III: blood vessels, healing wounds (with Type I). Type IV: basement membranes. Know which type in which tissue.

At a Glance

Collagen is the most abundant protein in mammals (25-35% of total body protein), characterised by a unique triple helix structure with the Gly-X-Y amino acid repeat. Type I collagen predominates in bone/tendon (90%), while Type II is found in hyaline cartilage. Proteoglycans consist of core proteins with negatively charged glycosaminoglycan (GAG) side chains that attract water - aggrecan is the major cartilage proteoglycan. Key exam points: Vitamin C is essential for proline/lysine hydroxylation (scurvy causes defective collagen), and lysyl oxidase (copper-dependent) creates crosslinks essential for tensile strength.

Mnemonic

COLLAGENCOLLAGEN - Key Features

C	Common protein (25-35% body) Most abundant protein in mammals
O	One-quarter is glycine Gly-X-Y repeat, glycine every 3rd residue
L	Lysyl oxidase crosslinks Creates covalent bonds between molecules
L	Long triple helix (300nm) Tropocollagen molecule
A	Aligned in fibrils Quarter-stagger 67nm D-band
G	Glycine must be central Small enough to fit in helix center
E	Extracellular assembly Procollagen processed outside cell
N	Nineteen fibril-forming types Types I, II, III, V, XI form fibrils

C	Common protein (25-35% body) Most abundant protein in mammals	L	Long triple helix (300nm) Tropocollagen molecule	E	Extracellular assembly Procollagen processed outside cell
O	One-quarter is glycine Gly-X-Y repeat, glycine every 3rd residue	A	Aligned in fibrils Quarter-stagger 67nm D-band	N	Nineteen fibril-forming types Types I, II, III, V, XI form fibrils
L	Lysyl oxidase crosslinks Creates covalent bonds between molecules	G	Glycine must be central Small enough to fit in helix center

Hook:COLLAGEN is the common protein with glycine repeats forming triple helix

Mnemonic

TYPESTYPES - Major Collagen Types

T	Type I - Tendon, bone (most common) 90% of total body collagen
Y	tYpe II - hYaline cartilage Smaller fibrils than Type I
P	tyPe III - blooD vessels (reticular) Found with Type I in skin, vessels
E	typE IV - basEmEnt mEmbranes Network-forming, non-fibrillar
S	Scurvy affects all types Vitamin C required for hydroxylation

T	Type I - Tendon, bone (most common) 90% of total body collagen	E	typE IV - basEmEnt mEmbranes Network-forming, non-fibrillar
Y	tYpe II - hYaline cartilage Smaller fibrils than Type I	S	Scurvy affects all types Vitamin C required for hydroxylation
P	tyPe III - blooD vessels (reticular) Found with Type I in skin, vessels

Hook:Know the TYPES of collagen: I in bone/tendon, II in cartilage, III in vessels, IV in basement membranes

Mnemonic

PROTEOGLYCANSPROTEOGLYCANS - Structure and Function

P	Protein core with GAG chains Core protein covalently linked to GAGs
R	Repel water into tissue Negative charges attract water
O	Osmotic pressure created Swelling pressure from hydration
T	Types: aggrecan, decorin, perlecan Tissue-specific proteoglycans
E	Each GAG is disaccharide repeat Repeating sugar units
O	Oh-so-negative charge (SO4-, COO-) Sulfate and carboxyl groups
G	GAGs: CS, KS, HS, DS, HA Five main GAG types
L	Large aggregates form Aggrecans bind to hyaluronan
Y	Year-long half-life (aggrecan) Slower turnover than proteins
C	Cartilage has highest content 4-7% of cartilage wet weight
A	Attract cations (Na+, Ca2+) Donnan equilibrium
N	Non-sulfated: hyaluronan Only GAG without sulfate
S	Sulfate groups key to function Provide negative charge

P	Protein core with GAG chains Core protein covalently linked to GAGs	E	Each GAG is disaccharide repeat Repeating sugar units	Y	Year-long half-life (aggrecan) Slower turnover than proteins	S	Sulfate groups key to function Provide negative charge
R	Repel water into tissue Negative charges attract water	O	Oh-so-negative charge (SO4-, COO-) Sulfate and carboxyl groups	C	Cartilage has highest content 4-7% of cartilage wet weight
O	Osmotic pressure created Swelling pressure from hydration	G	GAGs: CS, KS, HS, DS, HA Five main GAG types	A	Attract cations (Na+, Ca2+) Donnan equilibrium
T	Types: aggrecan, decorin, perlecan Tissue-specific proteoglycans	L	Large aggregates form Aggrecans bind to hyaluronan	N	Non-sulfated: hyaluronan Only GAG without sulfate

Hook:PROTEOGLYCANS have protein core with negatively-charged GAG chains attracting water

Overview

Collagen and proteoglycans are major components of extracellular matrix in connective tissues including bone, cartilage, tendon, ligament, and skin.

Why collagen and proteoglycans matter clinically:

Genetic Collagen Disorders

Mutations in collagen genes cause osteogenesis imperfecta (Type I), chondrodysplasias (Type II), vascular Ehlers-Danlos syndrome (Type III), and Alport syndrome (Type IV). Understanding collagen structure explains disease mechanisms.

Wound Healing and Tissue Repair

Collagen synthesis is essential for fracture healing, tendon repair, and wound closure. Type III collagen appears early in healing, later replaced by Type I. Factors impairing collagen synthesis (vitamin C deficiency, medications) delay healing.

Degenerative Diseases

Osteoarthritis involves proteoglycan loss and collagen network disruption. Intervertebral disc degeneration involves aggrecan degradation. Understanding normal structure is essential to understand pathology.

Biomaterial Design

Collagen-based scaffolds are used in cartilage repair and tissue engineering. Understanding collagen structure, crosslinking, and degradation informs biomaterial design.

Collagen as Structural Protein

Collagen is the most abundant protein in mammals (25-35% of total body protein). It provides structural framework and tensile strength in connective tissues. The unique triple helix structure with Gly-X-Y repeat is essential for collagen function.

Concepts and Molecular Structure

Collagen Triple Helix

Primary structure - Gly-X-Y repeat:

Glycine every third residue (Gly-X-Y)
X position: Often proline (28%)
Y position: Often hydroxyproline (38%)
Glycine is smallest amino acid, fits in helix center
Any other amino acid at glycine position disrupts helix

Secondary structure - Left-handed helix:

Each alpha chain forms left-handed helix (polyproline II type)
3 residues per turn
Extended structure (not compact like alpha-helix)

Tertiary structure - Right-handed superhelix:

Three alpha chains wrap around each other
Right-handed triple helix
Glycine residues at central axis (every third residue)
Proline and hydroxyproline stabilize helix
No internal hydrogen bonds within chains
Hydrogen bonds between chains

Tropocollagen molecule:

300 nm length
1.5 nm diameter
Molecular weight: ~300 kDa
Three chains: Type I has two alpha-1(I) and one alpha-2(I)
Type II has three identical alpha-1(II) chains

Glycine Mutations

Glycine substitutions in Type I collagen cause osteogenesis imperfecta. Glycine is the only amino acid small enough to fit in the center of the triple helix. Replacing glycine with larger amino acids (e.g., serine, cysteine) disrupts helix structure, causing brittle bones. Location of mutation affects severity.

The triple helix structure is fundamental to collagen function and stability.

Major Collagen Types

28 collagen types have been identified. The major types relevant to orthopaedics are Types I, II, III, IV, V, IX, X, and XI.

Major Collagen Types in Orthopaedic Tissues

Type	Structure	Tissue Distribution	Function	Clinical Significance
I	Fibril-forming [α1(I)]₂α2(I)	Bone, tendon, ligament, skin, dentin	Tensile strength, structural support	OI: mutations in COL1A1, COL1A2
II	Fibril-forming [α1(II)]₃	Hyaline cartilage, vitreous humor, nucleus pulposus	Compression resistance in cartilage	Chondrodysplasias, early OA
III	Fibril-forming [α1(III)]₃	Blood vessels, skin, reticular fibers, healing tissue	Elastic recoil, early wound healing	Vascular EDS (Type IV EDS)
IV	Network-forming [α1(IV)]₂α2(IV)	Basement membranes (all)	Filtration barrier, cell attachment	Alport syndrome (kidney, ear, eye)
V	Fibril-forming [α1(V)]₂α2(V)	Bone, cornea, with Type I	Regulates Type I fibril diameter	Classical EDS (with Type I)
IX	FACIT [α1(IX)]α2(IX)α3(IX)	Cartilage, vitreous, with Type II	Links Type II fibrils, resists shear	Multiple epiphyseal dysplasia
X	Network-forming [α1(X)]₃	Hypertrophic cartilage (growth plate)	Endochondral ossification	Schmid metaphyseal chondrodysplasia
XI	Fibril-forming [α1(XI)]α2(XI)α3(XI)	Cartilage, vitreous, with Type II	Regulates Type II fibril diameter	Stickler syndrome (with Type II)

Type I vs Type II Collagen

Type I collagen (bone, tendon, ligament) forms larger diameter fibrils (50-200 nm) and has high tensile strength. Type II collagen (cartilage) forms smaller diameter fibrils (20-40 nm) optimized for compression resistance. Type I has two alpha-1(I) and one alpha-2(I) chain. Type II has three identical alpha-1(II) chains (homotrimer).

Collagen classification:

Fibril-forming: Types I, II, III, V, XI (form D-banded fibrils)
FACIT (Fibril-Associated Collagens with Interrupted Triple helices): Types IX, XII, XIV
Network-forming: Types IV, VIII, X (basement membranes, specialized networks)
Anchoring fibrils: Type VII (epidermis-dermis junction)
Transmembrane: Types XIII, XVII, XXIII

Understanding tissue-specific collagen types is essential for orthopaedic basic science.

Clinical Relevance and Applications

Proteoglycans consist of core protein with covalently attached GAG side chains.

Proteoglycan Structure

Components:

Core protein: Synthesized on ribosomes, varies in size
GAG chains: Synthesized in Golgi, attached to core protein
Link protein: Stabilizes aggrecan-hyaluronan binding (aggrecan only)

GAG attachment:

GAGs attached to serine residues on core protein
Tetrasaccharide linker: xylose-galactose-galactose-glucuronic acid
Except keratan sulfate (attached to serine or threonine via N-acetylgalactosamine)

Size range:

Small: Decorin (40 kDa core, 1 GAG chain, total 90-140 kDa)
Medium: Perlecan (470 kDa core, multiple HS chains)
Large: Aggrecan (220 kDa core, ~100 CS chains, total 2-3 million Da)

Proteoglycans vary in size and GAG composition depending on tissue function.

Evidence Base

Collagen Structure and Stability

Shoulders MD, Raines RT • Annu Rev Biochem (2009)

Key Findings:

Collagen is a right-handed bundle of three left-handed polyproline II-type helices
Stereoelectronic effects and preorganisation (not just hydrogen bonding) drive triple-helix stability
Hydroxyproline in the Y position stabilises the helix via inductive/stereoelectronic effects
Self-assembly of type I tropocollagen reproduces native fibril properties in synthetic systems

Clinical Implication: This authoritative review underpins the modern understanding of why the Gly-X-Y repeat and proline hydroxylation are obligatory; it explains scurvy (loss of Hyp stabilisation) and the dominant-negative effect of glycine substitutions in osteogenesis imperfecta.

Verify on PubMed (PMID 19344236)

Proteoglycan Form and Function: A Comprehensive Nomenclature

Iozzo RV, Schaefer L • Matrix Biol (2015)

Key Findings:

Defines 43 distinct proteoglycan-encoding genes grouped into 4 classes by location
Classes: intracellular, cell-surface, pericellular and extracellular proteoglycans
Aggrecan (extracellular, modular) provides compressive stiffness in cartilage
Small leucine-rich proteoglycans (decorin, biglycan) regulate collagen fibrillogenesis and signalling

Clinical Implication: The reference nomenclature for proteoglycan biology. Proteoglycan (aggrecan) loss is the earliest detectable change in osteoarthritis, explaining the increased water content and reduced compressive stiffness seen on quantitative MRI (T1rho, dGEMRIC) in early disease.

Verify on PubMed (PMID 25701227)

Osteogenesis Imperfecta (Disease Primer)

Marini JC, Forlino A, Bächinger HP, et al • Nat Rev Dis Primers (2017)

Key Findings:

~85% of OI is caused by dominant mutations in the type I collagen genes COL1A1 or COL1A2
Mutations affect collagen quantity (haploinsufficiency, milder) or structure (glycine substitutions, more severe)
Recessive, dominant and X-linked defects in collagen processing/modification and osteoblast genes cause the remaining cases
Extra-skeletal features include blue sclerae, dentinogenesis imperfecta, hearing loss and cardiovascular involvement

Clinical Implication: Understanding collagen structure explains the genotype-phenotype correlation in OI: glycine substitutions act dominant-negatively by disrupting helix folding, and those nearer the C-terminus (where helix assembly nucleates) tend to produce more severe disease.

Verify on PubMed (PMID 28820180)

The Role of Aggrecan in Normal and Osteoarthritic Cartilage

Roughley PJ, Mort JS • J Exp Orthop (2014)

Key Findings:

Aggrecan bears chondroitin sulfate and keratan sulfate chains and aggregates with hyaluronan via link protein
Both aggrecanases (ADAMTS) and matrix metalloproteinases cleave aggrecan, but at distinct sites
Inflammation and overloading upregulate aggrecanolytic enzymes, depleting aggrecan in OA
Synovial-fluid aggrecan fragments serve as a marker of ongoing cartilage destruction

Clinical Implication: Aggrecan degradation biomarkers can flag early OA, and enhancing aggrecan synthesis while inhibiting its degradation is central to cartilage-repair strategies (ACI/MACI, stem-cell implantation).

Verify on PubMed (PMID 26914753)

Deletion of Active ADAMTS5 Prevents Cartilage Degradation (Landmark)

Glasson SS, Askew R, Sheppard B, et al • Nature (2005)

Key Findings:

First single-gene deletion shown to abrogate cartilage destruction in a model of OA
Mice lacking the ADAMTS5 catalytic domain were protected after surgical joint destabilisation
Identified ADAMTS5 (aggrecanase-2) as the primary aggrecanase in murine OA
Established the aggrecanase IGD cleavage site as a rational therapeutic target

Clinical Implication: This landmark animal study reframed OA as a proteolytically driven aggrecan-loss disease and launched the ADAMTS5/aggrecanase inhibitor programmes now in clinical trials as potential disease-modifying OA drugs.

Verify on PubMed (PMID 15800624)

The 2017 International Classification of the Ehlers-Danlos Syndromes

Guideline

Malfait F, Francomano C, Byers P, et al • Am J Med Genet C Semin Med Genet (2017)

Key Findings:

Replaced the 1998 Villefranche six-type nosology with 13 recognised EDS subtypes
Most subtypes arise from defects in collagen genes or collagen-modifying enzymes
Molecular confirmation is required for all subtypes except hypermobile EDS (clinical diagnosis)
Vascular EDS (type III collagen / COL3A1) carries the highest risk of arterial and visceral rupture

Clinical Implication: The current global standard for diagnosing heritable connective-tissue disorders. Recognising vascular EDS is critical orthopaedically because of catastrophic vessel rupture risk and fragile tissues that complicate surgery.

Verify on PubMed (PMID 28306229)

Basic Science Viva Scenarios

Use these scenarios to practise clinical reasoning and management decisions

CLINICAL SCENARIOStandard

Scenario 1: Collagen Triple Helix (~3 min)

CLINICAL PROMPT

"Describe the structure of the collagen triple helix. What is the significance of the Gly-X-Y repeat?"

PRACTICAL APPROACH

The collagen triple helix consists of three left-handed polyproline II-type helical alpha chains that wrap around each other to form a right-handed superhelix. The fundamental feature is the Gly-X-Y amino acid repeat where glycine appears every third residue. Glycine is the smallest amino acid and is the only one that fits in the center of the triple helix where the three chains come together. In the X and Y positions, proline is commonly found in the X position (28%) and hydroxyproline in the Y position (38%). Hydroxyproline, formed by post-translational hydroxylation of proline residues requiring Vitamin C, stabilizes the triple helix through stereoelectronic effects. The triple helix is stabilized by hydrogen bonds between chains rather than within chains. Each tropocollagen molecule is 300 nm long and 1.5 nm in diameter. The importance of the Gly-X-Y repeat is that any mutation replacing glycine with a larger amino acid disrupts the triple helix structure. This occurs in osteogenesis imperfecta where glycine substitutions in Type I collagen cause unstable triple helices resulting in brittle bones.

KEY CLINICAL POINTS

Three alpha chains form right-handed triple helix

Gly-X-Y repeat: glycine every third residue

Glycine is small enough to fit in helix center

X position: often proline, Y position: often hydroxyproline

Hydroxyproline stabilizes helix (requires Vitamin C for synthesis)

Tropocollagen: 300 nm length, 1.5 nm diameter

Glycine mutations disrupt helix causing OI

Hydrogen bonds between chains stabilize structure

COMMON PITFALLS

Confusing left-handed (individual chains) with right-handed (superhelix)

Not explaining why glycine must be every third residue

Forgetting hydroxyproline role in stability

Missing Vitamin C requirement

FURTHER QUESTIONS

"What enzyme hydroxylates proline and what does it require?"

"What happens in scurvy and why?"

"What is the difference between Type I and Type II collagen chains?"

CLINICAL SCENARIOChallenging

Scenario 2: Collagen Biosynthesis (~4 min)

CLINICAL PROMPT

"Describe the steps of collagen biosynthesis from translation to fibril formation. Where are crosslinks formed and why are they important?"

PRACTICAL APPROACH

Collagen biosynthesis involves intracellular and extracellular steps. First, pro-alpha chain mRNA is translated on ribosomes and the chains enter the rough ER. Second, hydroxylation occurs in the ER: prolyl hydroxylase converts proline to hydroxyproline, and lysyl hydroxylase converts lysine to hydroxylysine. Both require Vitamin C as cofactor. Hydroxyproline stabilizes the triple helix while hydroxylysine provides sites for glycosylation and crosslinking. Third, hydroxylysine residues are glycosylated with glucose and galactose in the ER and Golgi. Fourth, three pro-alpha chains assemble into procollagen triple helix, initiated by C-terminal propeptides. Fifth, procollagen is secreted from the cell and N- and C-terminal propeptides are cleaved by procollagen peptidases, creating tropocollagen (300 nm). Sixth, tropocollagen molecules self-assemble into fibrils with quarter-stagger arrangement creating 67 nm D-band periodicity. Finally, lysyl oxidase, a copper-dependent enzyme, oxidizes lysine and hydroxylysine residues to aldehydes which spontaneously condense to form covalent crosslinks. Immature crosslinks form initially (Schiff bases), which mature over time to pyridinoline and deoxypyridinoline. Crosslinks are essential for tensile strength. Without crosslinks, as in lathyrism from lysyl oxidase inhibition or copper deficiency, collagen fibrils lack strength and tissues are fragile.

KEY CLINICAL POINTS

Step 1: Translation in RER, pro-alpha chains

Step 2: Hydroxylation (proline, lysine) requires Vitamin C

Step 3: Glycosylation of hydroxylysine

Step 4: Triple helix formation (procollagen) in ER/Golgi

Step 5: Secretion, propeptide cleavage → tropocollagen (300 nm)

Step 6: Fibril self-assembly in quarter-stagger (67 nm D-band)

Step 7: Crosslink formation by lysyl oxidase (requires copper)

Crosslinks provide tensile strength (pyridinoline, deoxypyridinoline)

Scurvy: vitamin C deficiency → unstable collagen

Lathyrism: lysyl oxidase inhibition → no crosslinks, weak collagen

COMMON PITFALLS

Missing intracellular vs extracellular steps

Not explaining cofactors (Vitamin C, copper)

Forgetting propeptide cleavage step

Not connecting to diseases (scurvy, lathyrism, OI)

FURTHER QUESTIONS

"What is the D-band and why is it 67 nm?"

"What is the role of procollagen peptidases?"

"Why are pyridinoline crosslinks measured in urine?"

CLINICAL SCENARIOStandard

Scenario 3: Proteoglycan Structure (~3 min)

CLINICAL PROMPT

"Describe the structure of aggrecan. How does it provide compressive stiffness in articular cartilage?"

PRACTICAL APPROACH

Aggrecan is the major proteoglycan in articular cartilage, consisting of a core protein (220-250 kDa) with approximately 100 chondroitin sulfate chains and 60 keratan sulfate chains covalently attached, giving a total molecular weight of 2-3 million Da. Multiple aggrecan molecules (50-100) bind to a central hyaluronan backbone via their G1 domain, stabilized by link protein (40-45 kDa), forming massive aggregates of 50-200 million Da. The GAG side chains (chondroitin sulfate and keratan sulfate) have high fixed negative charge density from sulfate groups (SO₄⁻) and carboxyl groups (COO⁻). These negative charges attract cations (Na⁺, Ca²⁺) and water via Donnan osmotic equilibrium, creating swelling pressure of 0.1-0.3 MPa. This hydration and swelling pressure provides compressive stiffness. The collagen network in cartilage constrains this swelling, creating prestress in the tissue even without external load. When cartilage is compressed, water is forced out of the matrix and flows through the porous collagen-proteoglycan network. This biphasic behavior provides shock absorption and load distribution. The high proteoglycan content in the deep zone of cartilage (50-60 mg/mL) provides the greatest compressive stiffness where compressive loads are highest.

KEY CLINICAL POINTS

Aggrecan: core protein (220-250 kDa) + ~100 CS + ~60 KS chains

Total molecular weight: 2-3 million Da

Aggregates: 50-100 aggrecans bind to hyaluronan via link protein

Aggregate size: 50-200 million Da

GAG chains have high fixed negative charge (SO₄⁻, COO⁻)

Negative charges attract water via Donnan osmotic pressure

Swelling pressure (0.1-0.3 MPa) provides compressive stiffness

Collagen network constrains swelling (prestress)

Biphasic behavior: water flows under load (shock absorption)

COMMON PITFALLS

Not explaining aggregation with hyaluronan

Missing link protein role

Not connecting negative charge to water attraction

Forgetting collagen constrains swelling

FURTHER QUESTIONS

"What are the GAG types on aggrecan?"

"What is the link protein and what does it do?"

"How is aggrecan degraded in osteoarthritis?"

MCQ Practice Points

Clinical Pearl

Q: What is the predominant proteoglycan in articular cartilage and its function?

A: Aggrecan is the major proteoglycan, attached to hyaluronic acid via link protein forming large aggregates. Contains glycosaminoglycan (GAG) side chains (chondroitin sulfate, keratan sulfate). Highly negatively charged, attracting water creating osmotic swelling pressure that resists compressive loads. Loss of aggrecan is early OA feature.

Clinical Pearl

Q: What is the distribution of collagen types in articular cartilage?

A: Type II collagen: 90-95% of cartilage collagen, provides tensile strength. Type IX: Cross-links Type II fibrils. Type XI: Regulates fibril diameter. Type VI: Pericellular matrix around chondrocytes. Fibrocartilage (meniscus, labrum) contains Type I collagen. OA involves shift from Type II to Type I.

Clinical Pearl

Q: What is the water content of articular cartilage and its significance?

A: Articular cartilage is 65-80% water by weight. Water content highest in superficial zone, lowest in deep zone. Creates biphasic viscoelastic behavior - fluid pressurization under load. Water bound to proteoglycans (fixed charge density). Dehydration decreases compressive stiffness. OA shows increased water content paradoxically.

Clinical Pearl

Q: What are the structural zones of articular cartilage?

A: Superficial zone (10-20%): Collagen parallel to surface, highest water, flattened chondrocytes, lubricin secretion. Middle/transitional zone (40-60%): Random collagen orientation. Deep zone (30%): Collagen perpendicular, highest proteoglycan, columns of chondrocytes. Calcified zone: Anchors to subchondral bone via tidemark.

Clinical Pearl

Q: What is the triple helix structure of collagen?

A: Three polypeptide chains (α-chains) wind into right-handed triple helix. Stabilized by glycine at every third position (smallest amino acid fits helix center). Proline and hydroxyproline provide rigidity. Hydroxyproline requires Vitamin C (scurvy causes collagen defects). Cross-linking between molecules provides tensile strength.

Differential Diagnosis: Heritable Collagen/ECM Disorders

Glycine substitutions, defective hydroxylation/crosslinking, and proteoglycan-processing defects all converge on connective-tissue fragility but differ in the molecule affected and the dominant phenotype. This table is high-yield for distinguishing the classic ECM diseases in a viva.

Connective-Tissue Disorders by Molecular Defect

Disorder	Molecule / Gene	Defect Mechanism	Key Clinical Clue
Osteogenesis imperfecta	Type I collagen (COL1A1/COL1A2)	Glycine substitution or haploinsufficiency	Fragile bones, blue sclerae, dentinogenesis imperfecta
Vascular EDS	Type III collagen (COL3A1)	Reduced/abnormal type III collagen	Arterial, bowel and uterine rupture; thin translucent skin
Classical EDS	Type V collagen (COL5A1/COL5A2)	Disordered type I fibril regulation	Skin hyperextensibility, atrophic scars, hypermobility
Kniest / Stickler / SED	Type II collagen (COL2A1)	Defective cartilage collagen	Short stature, myopia/retinal detachment, early OA
Alport syndrome	Type IV collagen (COL4A3-5)	Defective basement-membrane network	Haematuria/renal failure, sensorineural deafness
Scurvy	Hydroxyproline (acquired)	Vitamin C deficiency → no prolyl hydroxylation	Perifollicular haemorrhage, gum bleeding, poor healing
Menkes disease	Lysyl oxidase activity (ATP7A, copper)	Copper deficiency → no crosslinking	Kinky hair, vascular tortuosity, bone fragility
Mucopolysaccharidoses	GAG-degrading enzymes (e.g. IDUA)	Lysosomal GAG accumulation	Dysostosis multiplex, stiff joints, organomegaly

Controversies & Areas of Uncertainty

ADAMTS5 vs ADAMTS4 in human OA

Glasson's mouse data established ADAMTS5 as the dominant aggrecanase in rodents, but the relative contribution of ADAMTS4 versus ADAMTS5 in human disease remains debated, complicating translation of selective inhibitors.

Glucosamine and chondroitin

GAG-precursor supplements are widely consumed, yet high-quality trials and meta-analyses show inconsistent, at best small, effects on pain and no convincing structure modification. Major guidelines (e.g. OARSI, NICE) do not recommend them for disease modification.

Intra-articular hyaluronic acid (viscosupplementation)

Despite a coherent biological rationale (restoring synovial HA), pooled evidence for clinically meaningful benefit in knee OA is weak and contested; recommendations differ markedly between societies.

Crosslink quality vs quantity in bone fragility

Beyond collagen volume, the ratio of enzymatic (pyridinoline) to non-enzymatic advanced-glycation-end-product crosslinks is increasingly implicated in age- and diabetes-related bone fragility, but is not yet a routine clinical metric.

Guidelines, Registries & Global Practice

Global Relevance and Epidemiology

Collagen and proteoglycan biochemistry is core basic-science content across all major fellowship exams (FRCS Tr&Orth, FRACS, EBOT/FEBOT, ABOS, DNB/MS, MRCS, SICOT).
Osteoarthritis, the dominant downstream disease of proteoglycan/collagen failure, affects an estimated 500+ million people worldwide and is a leading global cause of years lived with disability.
Heritable disorders provide the natural "knockout" experiments: OI incidence is roughly 1 in 15,000-20,000 births; EDS collectively around 1 in 5,000.

Side-by-Side Guidance (ECM-Targeted OA Therapies)

How Major Societies Treat ECM-Directed OA Interventions

Body / Region	Glucosamine & Chondroitin	Intra-articular Hyaluronic Acid
AAOS (US)	Not recommended (strong, against)	Not recommended for routine knee OA
NICE / BOA (UK)	Do not offer for OA	Do not offer for OA management
OARSI (international)	Not recommended for disease modification	Conditional/uncertain; context-dependent
ESCEO / EFORT (Europe)	Prescription crystalline glucosamine sulfate viewed more favourably	May be considered as add-on in some algorithms

Registry & Practice Variation

Joint registries (NJR UK, AJRR US, AOANJRR Australia, Swedish/Norwegian registries) capture the end-stage arthroplasty outcomes of cartilage matrix failure and increasingly track cartilage-repair and biologic procedures.
High-resource settings: access to cell-based cartilage repair (ACI/MACI), osteochondral grafting and quantitative MRI of cartilage matrix (T1rho, dGEMRIC) for early matrix assessment.
Limited-resource settings: emphasis on conservative load management, weight optimisation and addressing nutritional collagen cofactors (vitamin C, copper) where deficiency is endemic; advanced biologics are often unavailable.

Management Algorithm

PROTEOGLYCANS AND COLLAGEN

Clinical summary

Collagen Triple Helix

•Gly-X-Y repeat: glycine every 3rd residue (small enough for helix center)
•X = proline (28%), Y = hydroxyproline (38%)
•Three alpha chains: right-handed superhelix, 300 nm length, 1.5 nm diameter
•Type I: [α1(I)]₂α2(I), Type II: [α1(II)]₃ homotrimer

Collagen Biosynthesis

•Hydroxylation: Prolyl/lysyl hydroxylase (requires Vitamin C cofactor)
•Triple helix: C-terminal propeptides initiate assembly
•Propeptide cleavage: Procollagen → tropocollagen (300 nm)
•Fibril assembly: Quarter-stagger creates 67 nm D-band
•Crosslinks: Lysyl oxidase (requires copper) creates pyridinoline, deoxypyridinoline

Major Collagen Types

•Type I: Bone, tendon, ligament (90% of body collagen), OI mutations
•Type II: Hyaline cartilage, nucleus pulposus, chondrodysplasia mutations
•Type III: Blood vessels, skin, healing tissue, vascular EDS
•Type IV: Basement membranes (network-forming), Alport syndrome

Proteoglycan Structure

•Core protein + GAG side chains (chondroitin sulfate, keratan sulfate, etc)
•Aggrecan: 2-3 MDa, ~100 CS + ~60 KS chains
•Aggregates: 50-100 aggrecans bind hyaluronan via link protein (40-45 kDa)
•Decorin: Small (90-140 kDa), binds collagen, regulates fibril diameter

GAG Types

•Chondroitin sulfate (CS): GlcUA-GalNAc, 4- or 6-sulfate, cartilage/bone
•Keratan sulfate (KS): Gal-GlcNAc, 6-sulfate, cartilage (increases with age)
•Dermatan sulfate (DS): IdoUA-GalNAc, decorin GAG, regulates collagen
•Heparan sulfate (HS): High sulfation, basement membranes, growth factor binding
•Hyaluronan (HA): No sulfate, not protein-bound, aggregation backbone

Proteoglycan Function

•Fixed negative charge (SO₄⁻, COO⁻) attracts water via Donnan equilibrium
•Swelling pressure (0.1-0.3 MPa) provides compression resistance
•Collagen network constrains proteoglycan swelling (prestress)
•Aggrecan in cartilage: highest in deep zone (50-60 mg/mL)

Clinical Correlations

•Scurvy: Vitamin C deficiency → no hydroxyproline → unstable collagen
•Lathyrism: Lysyl oxidase inhibition (or Cu deficiency) → no crosslinks
•OI: Type I collagen mutations (glycine substitutions) → brittle bones
•OA: Aggrecanase (ADAMTS-4,5) cleaves aggrecan IGD → proteoglycan loss
•Urinary PYD/DPD: Bone resorption markers (crosslinks released)

Collagen Triple Helix

Primary structure - Gly-X-Y repeat:

Glycine every third residue (Gly-X-Y)
X position: Often proline (28%)
Y position: Often hydroxyproline (38%)
Glycine is smallest amino acid, fits in helix center
Any other amino acid at glycine position disrupts helix

Secondary structure - Left-handed helix:

Each alpha chain forms left-handed helix (polyproline II type)
3 residues per turn
Extended structure (not compact like alpha-helix)

Tertiary structure - Right-handed superhelix:

Three alpha chains wrap around each other
Right-handed triple helix
Glycine residues at central axis (every third residue)
Proline and hydroxyproline stabilize helix
No internal hydrogen bonds within chains
Hydrogen bonds between chains

Tropocollagen molecule:

300 nm length
1.5 nm diameter
Molecular weight: ~300 kDa
Three chains: Type I has two alpha-1(I) and one alpha-2(I)
Type II has three identical alpha-1(II) chains

Glycine Mutations

The triple helix structure is fundamental to collagen function and stability.

Type

Structure

Tissue Distribution

Function

Clinical Significance

Fibril-forming [α1(I)]₂α2(I)

Bone, tendon, ligament, skin, dentin

Tensile strength, structural support

OI: mutations in COL1A1, COL1A2

Fibril-forming [α1(II)]₃

Hyaline cartilage, vitreous humor, nucleus pulposus

Compression resistance in cartilage

Chondrodysplasias, early OA

III

Fibril-forming [α1(III)]₃

Blood vessels, skin, reticular fibers, healing tissue

Elastic recoil, early wound healing

Vascular EDS (Type IV EDS)

Network-forming [α1(IV)]₂α2(IV)

Basement membranes (all)

Filtration barrier, cell attachment

Alport syndrome (kidney, ear, eye)

Fibril-forming [α1(V)]₂α2(V)

Bone, cornea, with Type I

Regulates Type I fibril diameter

Classical EDS (with Type I)

FACIT [α1(IX)]α2(IX)α3(IX)

Cartilage, vitreous, with Type II

Links Type II fibrils, resists shear

Multiple epiphyseal dysplasia

Network-forming [α1(X)]₃

Hypertrophic cartilage (growth plate)

Endochondral ossification

Schmid metaphyseal chondrodysplasia

Fibril-forming [α1(XI)]α2(XI)α3(XI)

Cartilage, vitreous, with Type II

Regulates Type II fibril diameter

Stickler syndrome (with Type II)

Disorder

Molecule / Gene

Defect Mechanism

Key Clinical Clue

Osteogenesis imperfecta

Type I collagen (COL1A1/COL1A2)

Glycine substitution or haploinsufficiency

Fragile bones, blue sclerae, dentinogenesis imperfecta

Vascular EDS

Type III collagen (COL3A1)

Reduced/abnormal type III collagen

Arterial, bowel and uterine rupture; thin translucent skin

Classical EDS

Type V collagen (COL5A1/COL5A2)

Disordered type I fibril regulation

Skin hyperextensibility, atrophic scars, hypermobility

Kniest / Stickler / SED

Type II collagen (COL2A1)

Defective cartilage collagen

Short stature, myopia/retinal detachment, early OA

Alport syndrome

Type IV collagen (COL4A3-5)

Defective basement-membrane network

Haematuria/renal failure, sensorineural deafness

Scurvy

Hydroxyproline (acquired)

Vitamin C deficiency → no prolyl hydroxylation

Perifollicular haemorrhage, gum bleeding, poor healing

Menkes disease

Lysyl oxidase activity (ATP7A, copper)

Copper deficiency → no crosslinking

Kinky hair, vascular tortuosity, bone fragility

Mucopolysaccharidoses

GAG-degrading enzymes (e.g. IDUA)

Lysosomal GAG accumulation

Dysostosis multiplex, stiff joints, organomegaly

Body / Region

Glucosamine & Chondroitin

Intra-articular Hyaluronic Acid

AAOS (US)

Not recommended (strong, against)

Not recommended for routine knee OA

NICE / BOA (UK)

Do not offer for OA

Do not offer for OA management

OARSI (international)

Not recommended for disease modification

Conditional/uncertain; context-dependent

ESCEO / EFORT (Europe)

Prescription crystalline glucosamine sulfate viewed more favourably

May be considered as add-on in some algorithms

GAG	Disaccharide Repeat	Sulfation	Location	Function
Chondroitin sulfate (CS)	GlcUA-GalNAc	4-sulfate or 6-sulfate	Cartilage, bone, tendon	Hydration, compression resistance
Keratan sulfate (KS)	Gal-GlcNAc	6-sulfate	Cartilage, cornea	Hydration, increases with age
Dermatan sulfate (DS)	IdoUA-GalNAc	Variable sulfation	Skin, blood vessels, heart valves	Collagen fibril organization
Heparan sulfate (HS)	GlcUA/IdoUA-GlcNAc	High sulfation (N, 2-O, 6-O)	Basement membranes, cell surface	Growth factor binding, anticoagulation
Hyaluronan (HA)	GlcUA-GlcNAc	None (no sulfate)	Synovial fluid, cartilage, vitreous	Aggregation backbone, lubrication

GAG	Disaccharide Repeat	Sulfation	Location	Function
Chondroitin sulfate (CS)	GlcUA-GalNAc	4-sulfate or 6-sulfate	Cartilage, bone, tendon	Hydration, compression resistance
Keratan sulfate (KS)	Gal-GlcNAc	6-sulfate	Cartilage, cornea	Hydration, increases with age
Dermatan sulfate (DS)	IdoUA-GalNAc	Variable sulfation	Skin, blood vessels, heart valves	Collagen fibril organization
Heparan sulfate (HS)	GlcUA/IdoUA-GlcNAc	High sulfation (N, 2-O, 6-O)	Basement membranes, cell surface	Growth factor binding, anticoagulation
Hyaluronan (HA)	GlcUA-GlcNAc	None (no sulfate)	Synovial fluid, cartilage, vitreous	Aggregation backbone, lubrication

Proteoglycan	Main GAG	Primary Tissue	Key Function
Aggrecan	Chondroitin sulfate, keratan sulfate	Hyaline cartilage	Compression resistance
Decorin	Dermatan sulfate	Tendon, ligament, bone	Regulates collagen fibril diameter
Biglycan	Dermatan sulfate	Bone, tendon	Collagen organization, growth factor binding
Perlecan	Heparan sulfate	Basement membranes	Filtration, growth factor reservoir

Proteoglycans and Collagen in Connective Tissue

Proteoglycans and Collagen in Connective Tissue

MAJOR COLLAGEN TYPES

Critical Must-Knows

Clinical Pearls

Critical Collagen and Proteoglycan Exam Points

Triple Helix Structure

Post-Translational Modifications

Proteoglycan Structure

Tissue-Specific Distribution

At a Glance

COLLAGENCOLLAGEN - Key Features

TYPESTYPES - Major Collagen Types

PROTEOGLYCANSPROTEOGLYCANS - Structure and Function

Overview

Genetic Collagen Disorders

Wound Healing and Tissue Repair

Degenerative Diseases

Biomaterial Design

Concepts and Molecular Structure

Collagen Triple Helix

Collagen Biosynthesis Steps

Collagen Synthesis and Assembly

Vitamin C Deficiency - Scurvy

Copper Deficiency - Lathyrism

Collagen Fibril Structure

Collagen Crosslinks

Major Collagen Types

Major Collagen Types in Orthopaedic Tissues

Clinical Relevance and Applications

Proteoglycan Structure

Glycosaminoglycan (GAG) Types

Major GAG Types

Major Proteoglycans

Proteoglycan Tissue Distribution

Aggrecan Aggregation

Evidence Base

Collagen Structure and Stability

Proteoglycan Form and Function: A Comprehensive Nomenclature

Osteogenesis Imperfecta (Disease Primer)

The Role of Aggrecan in Normal and Osteoarthritic Cartilage

Deletion of Active ADAMTS5 Prevents Cartilage Degradation (Landmark)

The 2017 International Classification of the Ehlers-Danlos Syndromes

Basic Science Viva Scenarios

Scenario 1: Collagen Triple Helix (~3 min)

Scenario 2: Collagen Biosynthesis (~4 min)

Scenario 3: Proteoglycan Structure (~3 min)

MCQ Practice Points

Differential Diagnosis: Heritable Collagen/ECM Disorders

Connective-Tissue Disorders by Molecular Defect

Controversies & Areas of Uncertainty

ADAMTS5 vs ADAMTS4 in human OA

Glucosamine and chondroitin

Intra-articular hyaluronic acid (viscosupplementation)

Crosslink quality vs quantity in bone fragility

Guidelines, Registries & Global Practice

Global Relevance and Epidemiology

Side-by-Side Guidance (ECM-Targeted OA Therapies)

How Major Societies Treat ECM-Directed OA Interventions

Registry & Practice Variation

Management Algorithm

PROTEOGLYCANS AND COLLAGEN

Collagen Triple Helix

Collagen Biosynthesis

Major Collagen Types

Proteoglycan Structure

GAG Types

Proteoglycan Function

Clinical Correlations

Proteoglycans and Collagen in Connective Tissue

Proteoglycans and Collagen in Connective Tissue

MAJOR COLLAGEN TYPES

Critical Must-Knows

Clinical Pearls

Critical Collagen and Proteoglycan Exam Points

Triple Helix Structure

Post-Translational Modifications

Proteoglycan Structure

Tissue-Specific Distribution

At a Glance